These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26874268)

  • 21. Effect of sleep deprivation on the growth hormone response to the alpha-3 adrenergic receptor agonist, clonidine, in normal subjects.
    Lal S; Thavundayil JX; Krishnan B; Nair NP; Schwartz G; Kiely ME; Guyda H
    J Neural Transm (Vienna); 1997; 104(2-3):291-8. PubMed ID: 9203090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone-releasing factor stimulation test in depression.
    Krishnan KR; Manepalli AN; Ritchie JC; Rayasam K; Melville ML; Daughtry G; Thorner MO; Rivier JE; Vale WW; Nemeroff CB
    Am J Psychiatry; 1988 Jan; 145(1):90-2. PubMed ID: 2827532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults.
    Kimber J; Sivenandan M; Watson L; Mathias CJ
    Growth Horm IGF Res; 2001 Apr; 11(2):128-35. PubMed ID: 11472079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intrahypothalamic administration.
    Chapman IM; Kapoor R; Willoughby JO
    Neuroendocrinology; 1993 May; 57(5):921-7. PubMed ID: 8105398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations.
    Coplan JD; Smith EL; Trost RC; Scharf BA; Altemus M; Bjornson L; Owens MJ; Gorman JM; Nemeroff CB; Rosenblum LA
    Psychiatry Res; 2000 Aug; 95(2):93-102. PubMed ID: 10963795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-1- and 2-adrenoceptor subsensitivity in siblings of opioid addicts with personality disorders and depression.
    Gerra G; Caccavari R; Marcato A; Zaimovic A; Avanzini P; Monica C; Mutti A; Fontanesi B; Delsignore R; Brambilla F
    Acta Psychiatr Scand; 1994 Oct; 90(4):269-73. PubMed ID: 7831997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness.
    Amsterdam JD; Maislin G
    Biol Psychiatry; 1990 Aug; 28(4):308-14. PubMed ID: 2204433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM; Mönig H; Mill G; Gödde E; Schulte HM
    Exp Clin Endocrinol Diabetes; 1995; 103(3):205-8. PubMed ID: 7584524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chronic clonidine administration on GH secretion in adult human subjects.
    Catania A; Baldini M; Orsatti A; Airaghi L; Gasparini P; Cantalamessa L
    Exp Clin Endocrinol; 1991 Mar; 97(1):76-80. PubMed ID: 1907565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism.
    Giustina A; Buffoli MG; Bussi AR; Wehrenberg WB
    Horm Res; 1991; 36(5-6):192-5. PubMed ID: 1823078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.
    Charney DS; Heninger GR; Sternberg DE; Hafstad KM; Giddings S; Landis DH
    Arch Gen Psychiatry; 1982 Mar; 39(3):290-4. PubMed ID: 6279050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noradrenergic and dopaminergic interrelation in schizophrenia.
    Brambilla F; Marini S; Saito A; Fassone G; Picardi A; Nerozzi D; Pancheri P
    Psychiatry Res; 1994 Sep; 53(3):231-42. PubMed ID: 7870845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls.
    Hollander E; DeCaria C; Nitescu A; Cooper T; Stover B; Gully R; Klein DF; Liebowitz MR
    Psychiatry Res; 1991 May; 37(2):161-77. PubMed ID: 1876628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired growth hormone response to clonidine in obesity.
    Altomonte L; Zoli A; Mirone L; Berchicci M; Travaglini R; Pellicano P; Greco AV
    Exp Clin Endocrinol; 1988 Dec; 92(2):231-4. PubMed ID: 3243343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder.
    Martín-Blanco A; Ferrer M; Soler J; Arranz MJ; Vega D; Calvo N; Elices M; Sanchez-Mora C; García-Martinez I; Salazar J; Carmona C; Bauzà J; Prat M; Pérez V; Pascual JC
    Eur Arch Psychiatry Clin Neurosci; 2016 Jun; 266(4):307-16. PubMed ID: 26182893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal responses to clonidine and urinary MHPG in delusional and nondelusional melancholic patients: a placebo-controlled study.
    Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):77-81. PubMed ID: 1657199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone response to clonidine in neuroleptic-free patients with multidagnostically defined schizophrenia.
    Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hassett A; Matheson B; Hill C; Mackie B; Singh B; Hirt J
    Psychiatry Res; 1993 Jul; 48(1):79-90. PubMed ID: 8416019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.